Altamira Therapeutics Ltd. Adjustments For Income Tax Expense
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Income Tax Expense of -CHF 99.85 thousand for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForIncomeTaxExpense · last filed 2025-04-30
CHF
| Period end | Adjustments For Income Tax Expense 6 month | Adjustments For Income Tax Expense 12 month |
|---|---|---|
| 2023-12-31 | -99.85K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 10.60K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | -10.33K CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | -47.32K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | 21.62K CHF 20-F/A · filed 2024-04-22 | |
| 2021-06-30 | -10.64K CHF 6-K/A · filed 2023-08-21 | |
| 2020-12-31 | -21.28K CHF 20-F · filed 2023-05-16 | |
| 2020-06-30 | -10.64K CHF 6-K · filed 2021-09-08 | |
| 2019-12-31 | -193.84K CHF 20-F · filed 2022-04-12 | |
| 2019-06-30 | -261.39K CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | 162.18K CHF 20-F · filed 2021-03-31 | |
| 2018-06-30 | -17.45K CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | -17.77K CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | -131.06K CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 0.00 CHF 20-F · filed 2018-03-22 |
USD
| Period end | Adjustments For Income Tax Expense 6 month | Adjustments For Income Tax Expense 12 month |
|---|---|---|
| 2023-12-31 | -$111.13K 20-F · filed 2025-04-30 | |
| 2023-06-30 | $11.62K 6-K · filed 2024-09-24 | |
| 2022-12-31 | -$10.81K 20-F · filed 2025-04-30 |